HK Mid-Caps Poised for Overhaul Amid AI Supply Chain Shifts and M&AGlobal Report·Jul 28 at 04:12 AM03309+1.13%01709+3.86%
C-Mer Medical files next-day disclosure return to HKEX disclosing share buyback at HKD 0.95 average pricePUBT·Jul 23 at 07:09 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure return on share buyback at HKD 0.93PUBT·Jul 22 at 06:29 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure reporting share buyback for treasury sharesPUBT·Jul 21 at 06:06 AM03309+1.13%
C-Mer Medical files HKEX next-day return disclosing share buyback at HKD 0.99-high, HKD 0.98-lowPUBT·Jul 20 at 06:32 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure return reporting share repurchasePUBT·Jul 17 at 05:08 AM03309+1.13%
Kingmaker Footwear files HKEX next-day disclosure return on share repurchase for cancellationPUBT·Jul 14 at 04:45 AM011700.00%
C-Mer Medical files HKEX next-day return disclosing share buyback at HKD 0.93-0.94PUBT·Jul 13 at 04:32 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure return after share buyback at HKD 0.93–0.94PUBT·Jul 10 at 04:48 AM03309+1.13%
C-Mer Medical files HKEX next day disclosure return on share repurchase for cancellationPUBT·Jul 9 at 05:00 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure return on share buybackPUBT·Jul 8 at 03:53 AM03309+1.13%
C-Mer Medical files HKEX next-day disclosure reporting share repurchase for cancellationPUBT·Jul 6 at 08:07 PM03309+1.13%
C-Mer Medical files HKEX next-day disclosure return reporting share buybackPUBT·Jul 2 at 04:35 AM03309+1.13%
C-MER Seeks Exclusive Hong Kong, Macau Rights to New Eye Drug in Strategic Series B DealTip Ranks·Jun 30 at 05:47 AM03309+1.13%
C-Mer Medical says target approves Hong Kong, Macau exclusive rights for ZVS101e drug candidatePUBT·Jun 30 at 05:06 AM03309+1.13%
